Cargando…

Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin

We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical history of adult T-cell leukemia/lymphoma and colon can...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Tatsuro, Sakai, Takahiro, Matsuzaka, Kaori, Shioya, Haruna, Tominaga, Hiroo, Kaneko, Yohei, Hayashi, Shizuka, Matsuo, Masatoshi, Taguchi, Jun, Abe, Kuniko, Shigematsu, Kazuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772834/
https://www.ncbi.nlm.nih.gov/pubmed/33442363
http://dx.doi.org/10.1159/000511111